| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 17.329 | 58.938 | 73.200 | 86.387 |
| Total Income - EUR | - | - | - | - | - | - | 17.329 | 58.938 | 73.200 | 86.387 |
| Total Expenses - EUR | - | - | - | - | - | - | 434 | 758 | 8.620 | 10.100 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 16.894 | 58.179 | 64.580 | 76.288 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 16.374 | 56.746 | 63.848 | 73.696 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dr. Spârleanu Oana-Claudia S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 16.831 | 57.310 | 65.301 | 75.591 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 9.720 | 42.546 | 53.018 | 54.025 |
| Cash | - | - | - | - | - | - | 7.111 | 14.764 | 12.283 | 21.566 |
| Shareholders Funds | - | - | - | - | - | - | 16.415 | 56.795 | 63.896 | 73.744 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 416 | 515 | 1.404 | 1.847 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Spârleanu Oana-Claudia S.r.l.